At the histological subtype level, P53 mutations are frequently observed in the macrotrabecular-massive (MTM) subtype, a newly defined histological variant of HCC by the World Health Organization in 2019, characterized by its invasive biological behavior and unfavorable prognosis [9, 10]. This evidence concerns the gene TP53 and hepatocellular carcinoma.